Ignite Creation Date:
2024-05-05 @ 11:50 AM
Last Modification Date:
2024-10-26 @ 9:14 AM
Study NCT ID:
NCT00143247
Status:
TERMINATED
Last Update Posted:
2010-04-15
First Post:
2005-08-31
Brief Title:
Long-Term Safety Study of Inhaled Insulin An Up to Four-Year Extension of Therapy in Subjects With Type 1 or Type 2 Diabetes Mellitus
Sponsor:
Pfizer
Organization:
Pfizer
Study Overview
Official Title:
An Open-Label Phase 2 Long-Term Safety Study of Inhaled Insulin An Up to Four-Year Extension of Therapy in Subjects With Type 1 or Type 2 Diabetes Mellitus Participating in Extension Protocols 217-102 103 or 104
Status:
TERMINATED
Status Verified Date:
2009-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
See termination reason in detailed description
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is a long-term safety study for Phase 2 subjects who choose to remain on Exubera inhaled insulin
Detailed Description:
The study was terminated on Oct 18 2007 This study is not a post approval commitment study Pfizer decided to cancel new trials because of the decision to withdraw Exubera inhaled insulin due to lack of market performance and not for safety reasons
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None